Add like
Add dislike
Add to saved papers

Settling regimen transitions quantify solid separation limitations through correlation with floc size and shape.

Water Research 2017 Februrary 2
This study monitored three different activated sludge systems from the Blue Plains Advanced Wastewater Plant for a 1 year period to explore the relationship between effluent quality and activated sludge settling and flocculation behavior. Hindered settling rates (ISV) and sludge volume index (SVI) measurements were collected weekly. Novel metrics based on the solids concentration at which the transition between settling regimens occurred were also collected weekly. The transitional metrics were Threshold of Flocculation (TOF), and Limit of Stokesian Settling (LOSS). They marked the transition from discreet to flocculant settling, and from flocculant to hindered settling, respectively. A pilot clarifier and settling column were run and filmed to determine floc morphological properties. SVI was found to lose sensitivity (r < 0.20) when characterizing ISV above a hindered settling rate of 3 m h-1 . ISV and LOSS had a strong correlation (r = 0.71), but ISV was subject to change, depending on the solids concentration. Two sludge matrix limitations influencing effluent quality were characterized by transition concentrations; pinpoint floc formation, and loose floc formation. Pinpoint flocs had TOF values above 400 mg TSS L-1 ; loose floc formation sludge had TOF and LOSS values below 400 mg TSS L-1 and 900 mg TSS L-1 , respectively. TOF was found to correlate with the particle size distribution while LOSS correlated to the settling velocity distribution. The use of both TOF and LOSS is a quick and effective way to characterize limitations effecting effluent quality.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app